Skip to content
Medical Health Aged Care

RACGP urges RSV immunisation rollout to keep vulnerable Victorian infants safe

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs (RACGP) has called on the Victorian Government to follow other states’ lead and commit to rolling out an RSV immunisation program that will save lives.

Respiratory syncytial virus, or RSV, is common respiratory infection which mostly affects young children, including babies. The symptoms are usually mild and manageable at home; however, some children and adults can become extremely ill and require hospital treatment. There were more than 128,000 cases reported last year Australia-wide, causing symptoms that ranged from mild to life-threatening.

The Federal Department of Health and Aged Care’s disease surveillance tool shows cases in Victoria have increased from 3,400 cases in the first quarter of 2024 to 8,584 cases in the current, second quarter, surpassing Queensland in May.

More than half of all RSV cases are among infants and children under five. Research has found RSV is likely the most common reason for hospital presentation among infants aged 12 months or younger, and there has been a steady growth in global RSV hospitalisations since 2009.

Immunisation is available however, and clinical trials indicate an injectable antibody can reduce hospitalisations by 83%. Previously, the College welcomed action to tackle RSV through infant immunisation in Western Australia, New South Wales, and Queensland.

RACGP Victoria Chair Dr Anita Muñoz said immunisations for vulnerable infants will save lives. 

“This is an opportunity to prevent hospitalisation of babies and saves lives,” she said.

“Other states have taken action here, either making immunisations available to all new babies or through more targeted efforts.

“RSV is a serious disease that puts children in hospital every year. People may not realise the enormous health burden it places on children five and under in Australia. Not only is it likely the number one cause of hospitalisation among young children, up to a quarter of them need intensive care treatment. That’s an absolute nightmare for a young family to go through.

“With an immunisation program to match the one in Western Australia, we can keep children out of hospital beds, save families from a terrible experience, and be proactive about public health to relieve pressure on our health system, including our already under-pressure hospitals.”


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit To unsubscribe from RACGP media releases, click here.

Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699

Follow us on Twitter: @RACGP and Facebook.


More from this category

  • Medical Health Aged Care
  • 18/06/2024
  • 09:07

Former Facebook CEO (ANZ) Stephen Scheeler Announced as Keynote Speaker for Better Outcomes

SYDNEY, AUSTRALIA / ACCESSWIRE / June 17, 2024 / AlayaCare, a leading Home and Residential Care software provider, today announces Stephen Scheeler - former CEO of Facebook ANZ, renowned business leader, and digital innovation expert - as the keynote speaker at Better Outcomes 2024. Better Outcomes is AlayaCare's flagship user conference that will be held on 3 September in Sydney. Scheeler brings vast experience as a leader who drove Facebook's unprecedented rise in Australia and New Zealand, and as a strategic advisor to major corporations on digital disruption and the future of technology. Scheeler's insights, demonstrated by his contributions to…

  • Information Technology, Medical Health Aged Care
  • 18/06/2024
  • 09:01
Monash University

New AI tool for rapid and cost-effective drug discovery

Australian researchers, led by Monash University, have invented a new artificial intelligence (AI) tool which is poised to reshape virtual screening in early stage drug discovery and enhance scientists’ ability to identify potential new medicines. Although computational methods within drug discovery are well established, there is an indisputable gap when it comes to novel AI tools capable of rapidly, robustly and cost-effectively predicting the strength of interactions between molecules and proteins – a critical step in the drug discovery process. The Australian invention ‘PSICHIC’ (PhySIcoCHemICal) brings together expertise at the interface of computing technology and drug discovery to offer an…

  • Medical Health Aged Care
  • 18/06/2024
  • 09:00
Pacific Friends of Global Health

What’s Next for the Future of Immunisation?

On Tuesday, 18 June at 16:00h Central European Time, (01:00 AEST), Gavi, the Vaccine Alliance will be hosting a virtual media briefingtitled “What’s next for the future of immunisation?”. You will hear from leading experts from Gavi, theVaccine Alliance, the African Union/Africa CDC and the Government of France, on the latestdevelopments to ensure all children, particularly those living in the poorest areas, are protected fromvaccine-preventable diseases. Over the past several decades, health workers, governments, and global alliances have joined forces toeliminate diseases, extend life expectancies, and lift generations out of poverty. Since 2000, thecountries supported by the Vaccine Alliance have…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.